Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/18653
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMilionis, H. J.en
dc.contributor.authorElisaf, M. S.en
dc.date.accessioned2015-11-24T18:54:10Z-
dc.date.available2015-11-24T18:54:10Z-
dc.identifier.issn1097-6744-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18653-
dc.rightsDefault Licence-
dc.subjectAnticholesteremic Agents/*administration & dosageen
dc.subjectDrug Therapy, Combinationen
dc.subjectHeptanoic Acids/*administration & dosageen
dc.subjectHumansen
dc.subjectHypolipidemic Agents/*administration & dosageen
dc.subjectMetabolic Syndrome X/*drug therapyen
dc.subjectNiacin/*administration & dosageen
dc.subjectPyrroles/*administration & dosageen
dc.subjectSimvastatin/*administration & dosageen
dc.titleReply to Al-Shaer, is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome?en
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1016/j.ahj.2004.12.017-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/16084140-
heal.identifier.secondaryhttp://ac.els-cdn.com/S0002870304009172/1-s2.0-S0002870304009172-main.pdf?_tid=f916eac8534eede05ded20182f4551be&acdnat=1333534215_a60f70c47dd16cf9d7e61b18757b4c33-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2005-
heal.journalNameAm Heart Jen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Milionis-2005-Reply to Al-Shaer, i.pdf36.31 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons